| Financial Year |
March 31 2023 |
| Monetary Funds |
56,144,705,184.53 |
| Held-for-trading Financial Assets |
823,136.35 |
| Notes Receivable |
208,600,329.34 |
| Accounts Receivable |
2,973,743,110.41 |
| Advances to Suppliers |
15,965,580,189.62 |
| Other Receivables |
1,058,382,486.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
35,584,776,075.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
871,139,639.02 |
| Other Current Assets |
2,189,772,875.36 |
| Total Current Assets |
121,799,453,385.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,915,934,897.20 |
| Long-term Equity Investment |
9,961,595,844.95 |
| Investment Properties |
636,471,661.05 |
| Fixed Assetes |
18,973,940,012.71 |
| Under-construction Projects |
1,986,462,345.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,912,156,258.54 |
| R&D expenses |
-- |
| Goodwill |
144,231,195.67 |
| Long-Term Deferred and Prepaid Expenses |
215,112,321.53 |
| Deferred Income Tax Assets |
834,510,167.14 |
| Other Non-Current Assets |
3,210,801,607.62 |
| Sub-Total of Non-Current Assets |
43,511,992,683.54 |
| Total Assets |
165,311,446,069.40 |
| Short-Term Loans |
8,557,729,827.89 |
| Trading Financial liabilities |
54,295,611.42 |
| Notes Payable |
4,019,647,247.16 |
| Accounts Payable |
21,955,657,292.38 |
| Accounts Received In Advance |
101,382,572.69 |
| Employee Compensation Payable |
315,067,737.43 |
| Taxes Payable |
209,204,841.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
828,854,564.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,344,834,313.10 |
| Other Current Liabilities |
1,617,569,678.20 |
| Sub-Total of Current Liabilities |
94,072,257,653.04 |
| Long-term Loans |
14,945,570,067.69 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
56,900,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,304,315,606.66 |
| Deferred Income Tax Liabilities |
1,393,061,537.17 |
| Other Non-Current Liabilities |
998,133,002.29 |
| Sub-Total of Non-Current Liabilities |
21,551,417,543.42 |
| Total Liabilities |
115,623,675,196.46 |
| Paid-In Capital(Or Share Stock) |
4,472,428,758.00 |
| Capital Surplus |
33,816,530,085.68 |
| Surplus Reserve |
1,155,352,684.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,781,370,066.81 |
| Minority Stockholder's Interest |
4,117,810,121.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
45,569,960,751.29 |
| Owner's Equity（Stockholder's Equity） |
49,687,770,872.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
165,311,446,069.40 |
